Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coleman

Showing results (1211-1220 of 1,227) with videos related to

Pageof 123
Sort By:
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2020
A Novel Recurrent <i>COL5A1</i> Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular DysplasiaJulie Richer, Hannah L Hill, Yu Wang, et al.
Human Molecular Genetics|August 14, 2003
An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndromeW H Irwin McLean, Alan D Irvine, Kevin J Hamill, et al.
Micropublication Biology|April 1, 2025
Complete genome sequences of <i>Rhodococcus equi</i> phages CoffeeBean, Dorin, Francesca, Madraxi, and TonitrusOrin R Daspit, Andrew C Slagter, Drew VanWoerkom, et al.
Cell Reports|June 8, 2017
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate CancerAlfonso Urbanucci, Stefan J Barfeld, Ville Kytölä, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancerA Mandl, S Jasmine, Teg Krueger, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate CancerKomal Sharma, Divin A Wilson, Yu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramDae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Pageof 123

Showing results (1211-1220 of 1,227) with videos related to

Sort By:
Pageof 123
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2020
A Novel Recurrent <i>COL5A1</i> Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular DysplasiaJulie Richer, Hannah L Hill, Yu Wang, et al.
Human Molecular Genetics|August 14, 2003
An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndromeW H Irwin McLean, Alan D Irvine, Kevin J Hamill, et al.
Micropublication Biology|April 1, 2025
Complete genome sequences of <i>Rhodococcus equi</i> phages CoffeeBean, Dorin, Francesca, Madraxi, and TonitrusOrin R Daspit, Andrew C Slagter, Drew VanWoerkom, et al.
Cell Reports|June 8, 2017
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate CancerAlfonso Urbanucci, Stefan J Barfeld, Ville Kytölä, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancerA Mandl, S Jasmine, Teg Krueger, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate CancerKomal Sharma, Divin A Wilson, Yu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramDae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Pageof 123